Work

An open-label long-term Phase 3 study of CAM2029, an octreotide subcutaneous depot, in patients with acromegaly (ACROINNOVA 2): interim analysis of patient-reported outcomes

Year: 2024

Type: conference-abstract

Source: Endocrine Abstracts

DOI: 10.1530/endoabs.99.ep322

Authors: Diego Ferone, Pietro Maffei, Julie Silverstein, Spencer-Segal Joanna L., Alexsandra Gilis-Januszewska, Mirjana Doknic, Pinar Kadioglu, Pamela Freda, Laurence Katznelson, Yaylali Guzin Fidan, Maria Harrie, Agneta Svedberg, Pedroncelli Alberto M., Fredrik Tiberg

Language: English

Topic: Pituitary Gland Disorders and Treatments

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4396747865

Cites:

Cited by:

Related to: 10